{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T15:52:45Z","timestamp":1777650765099,"version":"3.51.4"},"reference-count":44,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2013,9,4]],"date-time":"2013-09-04T00:00:00Z","timestamp":1378252800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Transfusion"],"published-print":{"date-parts":[[2014,4]]},"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Cultured red blood cells (<jats:styled-content style=\"fixed-case\">cRBC<\/jats:styled-content>s) from cord blood (<jats:styled-content style=\"fixed-case\">CB<\/jats:styled-content>) have been proposed as transfusion products. Whether buffy coats discarded from blood donations (adult blood [<jats:styled-content style=\"fixed-case\">AB<\/jats:styled-content>]) may be used to generate <jats:styled-content style=\"fixed-case\">cRBC<\/jats:styled-content>s for transfusion has not been investigated.<\/jats:p><\/jats:sec><jats:sec><jats:title>Study Design and Methods<\/jats:title><jats:p>Erythroid progenitor cell content and numbers and blood group antigen profiles of erythroblasts (<jats:styled-content style=\"fixed-case\">ERYs<\/jats:styled-content>) and <jats:styled-content style=\"fixed-case\">cRBC<\/jats:styled-content>s generated in human erythroid massive amplification (<jats:styled-content style=\"fixed-case\">HEMA<\/jats:styled-content>) culture by <jats:styled-content style=\"fixed-case\">CB<\/jats:styled-content> (n\u2009=\u20097) and <jats:styled-content style=\"fixed-case\">AB<\/jats:styled-content> (n\u2009=\u200933, three females, three males, one <jats:styled-content style=\"fixed-case\">AB<\/jats:styled-content> with rare blood antigens cryopreserved using <jats:styled-content style=\"fixed-case\">CB<\/jats:styled-content> protocols) were compared.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Variability was observed both in progenitor cell content (twofold) and number of <jats:styled-content style=\"fixed-case\">ERYs<\/jats:styled-content> generated (1\u2009log) by <jats:styled-content style=\"fixed-case\">CB<\/jats:styled-content> and <jats:styled-content style=\"fixed-case\">AB<\/jats:styled-content> in <jats:styled-content style=\"fixed-case\">HEMA<\/jats:styled-content>. The average progenitor cell contents of the subset of <jats:styled-content style=\"fixed-case\">AB<\/jats:styled-content> and <jats:styled-content style=\"fixed-case\">CB<\/jats:styled-content> analyzed were similar. <jats:styled-content style=\"fixed-case\">AB<\/jats:styled-content> generated numbers of <jats:styled-content style=\"fixed-case\">ERY<\/jats:styled-content>s three times lower (p\u2009&lt;\u20090.01) than <jats:styled-content style=\"fixed-case\">CB<\/jats:styled-content> in <jats:styled-content style=\"fixed-case\">HEMA<\/jats:styled-content> containing fetal bovine serum but similar to <jats:styled-content style=\"fixed-case\">CB<\/jats:styled-content> in <jats:styled-content style=\"fixed-case\">HEMA<\/jats:styled-content> containing human proteins. Female <jats:styled-content style=\"fixed-case\">AB<\/jats:styled-content> contained two times fewer (p\u2009&lt;\u20090.05) erythroid progenitor cells but generated numbers of <jats:styled-content style=\"fixed-case\">ERY<\/jats:styled-content>s similar to those generated by male <jats:styled-content style=\"fixed-case\">AB<\/jats:styled-content>. Cryopreserved <jats:styled-content style=\"fixed-case\">AB<\/jats:styled-content> with a rare blood group phenotype and shipped to another laboratory generated great numbers of <jats:styled-content style=\"fixed-case\">ERY<\/jats:styled-content>s, 90% of which matured into <jats:styled-content style=\"fixed-case\">cRBC<\/jats:styled-content>s. Blood group antigen expression was consistent with the donor genotype for <jats:styled-content style=\"fixed-case\">ERY<\/jats:styled-content>s generated both by <jats:styled-content style=\"fixed-case\">CB<\/jats:styled-content> and <jats:styled-content style=\"fixed-case\">AB<\/jats:styled-content> but concordant with that of native <jats:styled-content style=\"fixed-case\">RBC<\/jats:styled-content>s only for cells derived from <jats:styled-content style=\"fixed-case\">AB<\/jats:styled-content>.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Buffy coats from regular donors, including a donor with rare phenotypes stored under conditions established for <jats:styled-content style=\"fixed-case\">CB<\/jats:styled-content>, are not inferior to <jats:styled-content style=\"fixed-case\">CB<\/jats:styled-content> for the generation of <jats:styled-content style=\"fixed-case\">cRBC<\/jats:styled-content>s.<\/jats:p><\/jats:sec>","DOI":"10.1111\/trf.12391","type":"journal-article","created":{"date-parts":[[2013,9,5]],"date-time":"2013-09-05T03:04:10Z","timestamp":1378350250000},"page":"1059-1070","source":"Crossref","is-referenced-by-count":11,"title":["Mononuclear cells from a rare blood donor, after freezing under good manufacturing practice conditions, generate red blood cells that recapitulate the rare blood phenotype"],"prefix":"10.1111","volume":"54","author":[{"given":"Francesca","family":"Masiello","sequence":"first","affiliation":[{"name":"Hematology\/Oncology and Molecular Medicine Istituto Superiore di Sanita'  Rome Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valentina","family":"Tirelli","sequence":"additional","affiliation":[{"name":"Hematology\/Oncology and Molecular Medicine Istituto Superiore di Sanita'  Rome Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Massimo","family":"Sanchez","sequence":"additional","affiliation":[{"name":"Cell Biology and Neuroscience Istituto Superiore di Sanita'  Rome Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emile","family":"van den Akker","sequence":"additional","affiliation":[{"name":"Sanquin Blood Supply  Amsterdam the Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Girelli","family":"Gabriella","sequence":"additional","affiliation":[{"name":"Centro Trasfusionale Universita' La Sapienza  Rome Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maurizio","family":"Marconi","sequence":"additional","affiliation":[{"name":"Centro Trasfusionale e di Immunoematologia, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico  Milan Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Antonietta","family":"Villa","sequence":"additional","affiliation":[{"name":"Centro Trasfusionale e di Immunoematologia, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico  Milan Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paolo","family":"Rebulla","sequence":"additional","affiliation":[{"name":"Centro Trasfusionale e di Immunoematologia, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico  Milan Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ghazala","family":"Hashmi","sequence":"additional","affiliation":[{"name":"MihLabs  Warren New Jersey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carolyn","family":"Whitsett","sequence":"additional","affiliation":[{"name":"Kings County Hospital and Downstate Medical Center  Brooklyn New York"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna Rita","family":"Migliaccio","sequence":"additional","affiliation":[{"name":"Hematology\/Oncology and Molecular Medicine Istituto Superiore di Sanita'  Rome Italy"},{"name":"Tisch Cancer Institute Mount Sinai School of Medicine  New York New York"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2013,9,4]]},"reference":[{"key":"e_1_2_8_2_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00439-009-0738-2"},{"key":"e_1_2_8_3_1","doi-asserted-by":"publisher","DOI":"10.1097\/MOH.0b013e3283316bed"},{"key":"e_1_2_8_4_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-07-077370"},{"key":"e_1_2_8_5_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2010.03024.x"},{"key":"e_1_2_8_6_1","doi-asserted-by":"publisher","DOI":"10.1111\/trf.12146"},{"key":"e_1_2_8_7_1","first-page":"2","article-title":"Rare gems: null phenotypes and blood groups","volume":"8","author":"Flegel WA","year":"2010","journal-title":"Blood Transfus"},{"key":"e_1_2_8_8_1","unstructured":"Food and Drug Administration.Alphabetical list of licensed establishments including product approval dates information updated through July 31 2013. [cited July 31 2013] Available from: URL:http:\/\/www.fda.gov\/downloads\/BiologicsBloodVaccines\/UCM149969.pdf"},{"key":"e_1_2_8_9_1","doi-asserted-by":"crossref","first-page":"239","DOI":"10.21307\/immunohematology-2019-456","article-title":"Review: American rare donor program","volume":"20","author":"Flickinger C","year":"2004","journal-title":"Immunohematology"},{"key":"e_1_2_8_10_1","first-page":"1","article-title":"The Lombardy rare donor Program","volume":"21","author":"Revelli N","year":"2013","journal-title":"Blood Transfus"},{"key":"e_1_2_8_11_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V73.1.100.100"},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V92.10.3658"},{"key":"e_1_2_8_13_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V94.2.550"},{"key":"e_1_2_8_14_1","doi-asserted-by":"publisher","DOI":"10.1006\/bcmd.2002.0502"},{"key":"e_1_2_8_15_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-03-1002"},{"key":"e_1_2_8_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.stem.2012.01.001"},{"key":"e_1_2_8_17_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-06-362038"},{"key":"e_1_2_8_18_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2008.01828.x"},{"key":"e_1_2_8_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tmrv.2011.01.002"},{"key":"e_1_2_8_20_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2010.023556"},{"key":"e_1_2_8_21_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-05-157198"},{"key":"e_1_2_8_22_1","doi-asserted-by":"publisher","DOI":"10.3727\/096368909X485049"},{"key":"e_1_2_8_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2008.02.008"},{"key":"e_1_2_8_24_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2008.02013.x"},{"key":"e_1_2_8_25_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2009.02329.x"},{"key":"e_1_2_8_26_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2009.019828"},{"key":"e_1_2_8_27_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V96.8.2717"},{"key":"e_1_2_8_28_1","doi-asserted-by":"publisher","DOI":"10.1006\/clin.1994.1003"},{"key":"e_1_2_8_29_1","doi-asserted-by":"publisher","DOI":"10.5966\/sctm.2012-0097"},{"key":"e_1_2_8_30_1","first-page":"4425","article-title":"Important facet of functional cRBCs","volume":"93","author":"Ainstee D","year":"1999","journal-title":"Blood"},{"key":"e_1_2_8_31_1","doi-asserted-by":"publisher","DOI":"10.1002\/stem.1136"},{"key":"e_1_2_8_32_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.92.22.10119"},{"key":"e_1_2_8_33_1","doi-asserted-by":"publisher","DOI":"10.1089\/scd.1.1996.5.161"},{"key":"e_1_2_8_34_1","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1001\/jama.1988.03410010073038","article-title":"Effect of repeated whole blood donations on serum immunoreactive erythropoietin levels in autologous donors","volume":"260","author":"Kickler TS","year":"1988","journal-title":"JAMA"},{"key":"e_1_2_8_35_1","first-page":"609","article-title":"Erythropoietin for mobilization of circulating progenitor cells in patients with previously treated relapsed malignancies","volume":"23","author":"Kessinger A","year":"1995","journal-title":"Exp Hematol"},{"key":"e_1_2_8_36_1","doi-asserted-by":"publisher","DOI":"10.1007\/s002770050296"},{"key":"e_1_2_8_37_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-10-314187"},{"key":"e_1_2_8_38_1","doi-asserted-by":"publisher","DOI":"10.1086\/423140"},{"key":"e_1_2_8_39_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00232-002-1053-1"},{"key":"e_1_2_8_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellimm.2012.06.008"},{"key":"e_1_2_8_41_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4614-4118-2_10"},{"key":"e_1_2_8_42_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1423-0410.1999.7710058.x"},{"key":"e_1_2_8_43_1","volume-title":"Guide to the preparation, use and quality assurance of blood components","author":"Council of Europe","year":"2006"},{"key":"e_1_2_8_44_1","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-199805150-00024"},{"key":"e_1_2_8_45_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-01-330514"}],"container-title":["Transfusion"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Ftrf.12391","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/trf.12391","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,2]],"date-time":"2023-10-02T01:09:40Z","timestamp":1696208980000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/trf.12391"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9,4]]},"references-count":44,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,4]]}},"alternative-id":["10.1111\/trf.12391"],"URL":"https:\/\/doi.org\/10.1111\/trf.12391","archive":["Portico"],"relation":{},"ISSN":["0041-1132","1537-2995"],"issn-type":[{"value":"0041-1132","type":"print"},{"value":"1537-2995","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,9,4]]}}}